Search results
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 1 day ago“The summer wave is coming, and the vaccine does offer quite a bit of protection against the [FliRT]...
Moderna’s New Flu-COVID Combi mRNA Vaccine Outperforms Separate Shots In Trials
IFLScience· 3 days agoModerna became a household name thanks to the success of its mRNA vaccine against COVID-19. Along...
Pentagon ran secret anti-vax campaign to undermine China during pandemic
USA TODAY via Yahoo News· 5 hours agoThe difficulty in vaccinating the population contributed to the worst death rate in the region. A...
KP.3 is the dominant COVID-19 variant in the US: Latest on test positivity, deaths, symptoms
USA TODAY via Yahoo News· 1 day agoDuring the Vaccines and Related Biological Products Advisory Committee, health experts from vaccine manufacturers Pfizer, Moderna and ...
US FDA expands GSK's RSV vaccine approval to adults aged 50 to 59
Reuters via Yahoo News· 7 days agoThe shot, branded Arexvy, and vaccines from rivals Pfizer and Moderna are already approved for...
Indonesia ramps up fight against tuberculosis amid concerns on economic impact
WSAU Wausau· 5 days agoJAKARTA (Reuters) - Indonesia plans to run clinical trials of several vaccines to fight surging...
Pfizer's Paxlovid fails as 15-day treatment for long COVID, study finds
FOX Business· 6 days agoA 15-day course of Pfizer's COVID-19 antiviral treatment Paxlovid did not relieve symptoms of long...
Another COVID vaccine? Yes, and here’s why
Denver Post· 3 days agoWhen compared against results from the original shot, the benefit of the new shot may seem modest. That’s because the original vaccines were given to a...
FDA Gives Nod to RSV Vaccine for People in Their 50s
US News & World Report· 4 days agoThe U.S. Food and Drug Administration on Friday has for the first time approved the use of a respiratory syncytial virus (RSV) vaccine for people in their 50s who are at increased ...
Pfizer Provides Update on Phase 3 Study of Investigational Gene Therapy for Ambulatory Boys with...
Morningstar· 2 days agoPfizer Inc. (NYSE: PFE) today announced that CIFFREO, a Phase 3 global, multicenter, randomized, double-blind, placebo-controlled study evaluating the investigational mini-dystrophin ...
